Shilanski & Associates Inc. Reduces Position in Relx Plc (NYSE:RELX)

Shilanski & Associates Inc. decreased its position in Relx Plc (NYSE:RELXFree Report) by 7.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,501 shares of the technology company’s stock after selling 448 shares during the period. Shilanski & Associates Inc.’s holdings in Relx were worth $250,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Venturi Wealth Management LLC increased its holdings in shares of Relx by 0.9% during the 3rd quarter. Venturi Wealth Management LLC now owns 24,164 shares of the technology company’s stock worth $1,147,000 after buying an additional 214 shares during the last quarter. Ballentine Partners LLC raised its position in Relx by 1.4% in the third quarter. Ballentine Partners LLC now owns 17,306 shares of the technology company’s stock valued at $821,000 after purchasing an additional 240 shares during the period. Marshall Financial Group LLC lifted its stake in shares of Relx by 0.8% in the 3rd quarter. Marshall Financial Group LLC now owns 30,515 shares of the technology company’s stock valued at $1,448,000 after purchasing an additional 246 shares during the last quarter. Procyon Advisors LLC grew its holdings in shares of Relx by 4.1% during the 3rd quarter. Procyon Advisors LLC now owns 6,734 shares of the technology company’s stock worth $320,000 after purchasing an additional 265 shares during the period. Finally, Axxcess Wealth Management LLC increased its position in shares of Relx by 5.3% during the 3rd quarter. Axxcess Wealth Management LLC now owns 5,270 shares of the technology company’s stock worth $250,000 after purchasing an additional 266 shares during the last quarter. Institutional investors and hedge funds own 15.02% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on RELX. StockNews.com began coverage on shares of Relx in a research report on Wednesday, October 30th. They set a “hold” rating for the company. Redburn Atlantic began coverage on Relx in a research report on Wednesday, January 8th. They issued a “buy” rating on the stock.

Read Our Latest Stock Analysis on Relx

Relx Stock Performance

Shares of Relx stock opened at $49.33 on Friday. The company has a current ratio of 0.48, a quick ratio of 0.42 and a debt-to-equity ratio of 1.63. The company has a 50 day moving average of $46.57 and a 200 day moving average of $46.65. Relx Plc has a 52-week low of $40.25 and a 52-week high of $49.57.

Relx Company Profile

(Free Report)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Featured Stories

Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELXFree Report).

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.